U.S. nears approval of Genzyme drug
Genzyme Corp's experimental drug for Fabry disease has won qualified support from an advisory committee to the U.S. Food and Drug Administration, increasing the probability that the drug will be
Genzyme Corp's experimental drug for Fabry disease has won qualified support from an advisory committee to the U.S. Food and Drug Administration, increasing the probability that the drug will be